JG
MPLT

Jain Global’s MapLight Therapeutics MPLT Stock Holding History

Jain Global’s Portfolio MPLT Stock Details MPLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Buy
+45,551
New +$1.31M 0.01% 835
2026
Q1 		– Sell
-327,693
Closed -$5.76M – 1741
2025
Q4 		$5.76M Buy
+327,693
New +$5.49M 0.03% 409

Other funds holding MPLT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jain Global's MPLT Position: Q2 2026 in Review

Jain Global opened a new position in MapLight Therapeutics (MPLT) in Q2 2026: 45,551 shares worth $1.63M. The stake represents 0.01% of the portfolio and ranks #835 among its holdings. This is a return to the name: Jain Global previously reported a position in MPLT as recently as Q4 2025.

Jain Global first reported a position in MPLT in Q4 2025 and has held it in 2 quarters since. The position peaked at $5.76M in Q4 2025. 100 funds tracked by Wall St. Rank hold MPLT as of Q2 2026.

  • Jain Global held 45,551 shares of MapLight Therapeutics worth $1.63M as of Q2 2026.
  • MapLight Therapeutics was a new Jain Global position in Q2 2026.
  • MapLight Therapeutics made up 0.01% of Jain Global's portfolio in Q2 2026, its #835 holding.
  • Jain Global first reported a position in MapLight Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Jain Global's MapLight Therapeutics position peaked at $5.76M in Q4 2025.
  • 100 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.